[go: up one dir, main page]

NO20020364L - Use of flupirtine to relieve pain in degenerative joint disease in dogs and cats - Google Patents

Use of flupirtine to relieve pain in degenerative joint disease in dogs and cats

Info

Publication number
NO20020364L
NO20020364L NO20020364A NO20020364A NO20020364L NO 20020364 L NO20020364 L NO 20020364L NO 20020364 A NO20020364 A NO 20020364A NO 20020364 A NO20020364 A NO 20020364A NO 20020364 L NO20020364 L NO 20020364L
Authority
NO
Norway
Prior art keywords
flupirtine
cats
dogs
relieve pain
joint disease
Prior art date
Application number
NO20020364A
Other languages
Norwegian (no)
Other versions
NO20020364D0 (en
Inventor
Gabriele Endler
Holger Lehmann
Michael Lobich
Istvan Szelenyi
Original Assignee
Bayer Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bayer Ag filed Critical Bayer Ag
Publication of NO20020364L publication Critical patent/NO20020364L/en
Publication of NO20020364D0 publication Critical patent/NO20020364D0/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/28—Asteraceae or Compositae (Aster or Sunflower family), e.g. chamomile, feverfew, yarrow or echinacea
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/415—1,2-Diazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/415—1,2-Diazoles
    • A61K31/4152—1,2-Diazoles having oxo groups directly attached to the heterocyclic ring, e.g. antipyrine, phenylbutazone, sulfinpyrazone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/4415—Pyridoxine, i.e. Vitamin B6
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/506—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim not condensed and containing further heterocyclic rings
    • A61K31/51—Thiamines, e.g. vitamin B1
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/57—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
    • A61K31/573—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone substituted in position 21, e.g. cortisone, dexamethasone, prednisone or aldosterone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7135—Compounds containing heavy metals
    • A61K31/714—Cobalamins, e.g. cyanocobalamin, i.e. vitamin B12
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A61K31/737—Sulfated polysaccharides, e.g. chondroitin sulfate, dermatan sulfate
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/76—Salicaceae (Willow family), e.g. poplar
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Botany (AREA)
  • Medical Informatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Biotechnology (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Mycology (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Microbiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pain & Pain Management (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Rheumatology (AREA)
  • Molecular Biology (AREA)
  • Neurosurgery (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Immunology (AREA)
  • Neurology (AREA)
  • Dermatology (AREA)
  • Biomedical Technology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pyridine Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Fodder In General (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
NO20020364A 1999-08-03 2002-01-23 Use of flupirtine to relieve pain in degenerative joint disease in dogs and cats NO20020364D0 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US14703399P 1999-08-03 1999-08-03
PCT/EP2000/007356 WO2001008682A2 (en) 1999-08-03 2000-07-29 Use of flupirtine for alleviating pain caused by degenerative joint diseases in dogs and cats

Publications (2)

Publication Number Publication Date
NO20020364L true NO20020364L (en) 2002-01-23
NO20020364D0 NO20020364D0 (en) 2002-01-23

Family

ID=22520069

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20020364A NO20020364D0 (en) 1999-08-03 2002-01-23 Use of flupirtine to relieve pain in degenerative joint disease in dogs and cats

Country Status (20)

Country Link
EP (1) EP1242078A2 (en)
JP (1) JP2003530308A (en)
KR (1) KR20020040767A (en)
CN (1) CN1399550A (en)
AR (1) AR025030A1 (en)
AU (1) AU7271700A (en)
BR (1) BR0012942A (en)
CA (1) CA2314746A1 (en)
CO (1) CO5180569A1 (en)
CZ (1) CZ2002411A3 (en)
HR (1) HRP20020192A2 (en)
HU (1) HUP0301296A2 (en)
IL (1) IL147667A0 (en)
MX (1) MXPA02000997A (en)
NO (1) NO20020364D0 (en)
PL (1) PL354484A1 (en)
RU (1) RU2002105502A (en)
SK (1) SK1712002A3 (en)
WO (1) WO2001008682A2 (en)
ZA (1) ZA200200493B (en)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE10312346A1 (en) * 2003-03-20 2004-09-30 Bayer Healthcare Ag Controlled release system
CA2550023C (en) 2003-12-16 2011-04-12 Cnsbio Pty Ltd Treatment of neuropathic pain
AU2004298288B2 (en) * 2003-12-16 2011-06-30 Relevare Aust. Pty Ltd Methods and compositions
US7553858B2 (en) * 2003-12-17 2009-06-30 Meda Pharma Gmbh & Co. Kg Combination of flupirtine and tramadol
DE102004001558A1 (en) * 2004-01-10 2005-08-18 Bayer Healthcare Ag Medicinal products for topical application in animals
EP1789028A2 (en) * 2004-08-24 2007-05-30 Neuromolecular Pharmaceuticals Inc Compositions for treating nociceptive pain
KR101067443B1 (en) * 2009-06-23 2011-09-27 여오영 Topical injectable compositions for the treatment of hemorrhoids containing hydroxychloroquine
ITMI20120896A1 (en) * 2012-05-23 2013-11-24 Bongulielmi Reto CONDROITIN FOR USE IN MEDICINE
CN104523634A (en) * 2014-11-21 2015-04-22 哈尔滨圣吉药业股份有限公司 Flupirtine maleate sustained release tablet and preparation method thereof
RU2680244C1 (en) * 2017-12-28 2019-02-19 Общество С Ограниченной Ответственностью "Валента-Интеллект" Combination of flupirtine and cyclobenzaprine for treatment of pain syndromes
CN111371527B (en) 2018-12-25 2021-08-13 华为技术有限公司 A data transmission method and communication device

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0189788B1 (en) * 1985-01-23 1989-09-13 ASTA Pharma Aktiengesellschaft Synergistic combination of flupirtin and non-steroidal anti-phlogistics
FI855016A7 (en) * 1985-06-28 1986-12-29 Degussa Synergistic combination of flupirtine and 4-acetamido-phenol.
IN172468B (en) * 1990-07-14 1993-08-14 Asta Medica Ag
DE4236752A1 (en) * 1992-10-30 1994-05-05 Asta Medica Ag Combination preparation of flupirtine and morphine for the treatment of pain and for avoiding morphine addiction

Also Published As

Publication number Publication date
RU2002105502A (en) 2004-03-20
WO2001008682A2 (en) 2001-02-08
IL147667A0 (en) 2002-08-14
WO2001008682A3 (en) 2002-07-18
PL354484A1 (en) 2004-01-26
HRP20020192A2 (en) 2004-02-29
AR025030A1 (en) 2002-11-06
CZ2002411A3 (en) 2003-03-12
CO5180569A1 (en) 2002-07-30
HUP0301296A2 (en) 2003-08-28
SK1712002A3 (en) 2003-03-04
BR0012942A (en) 2002-07-09
KR20020040767A (en) 2002-05-30
MXPA02000997A (en) 2003-10-14
NO20020364D0 (en) 2002-01-23
ZA200200493B (en) 2003-04-30
CA2314746A1 (en) 2001-02-03
CN1399550A (en) 2003-02-26
JP2003530308A (en) 2003-10-14
AU7271700A (en) 2001-02-19
EP1242078A2 (en) 2002-09-25

Similar Documents

Publication Publication Date Title
NO20020364D0 (en) Use of flupirtine to relieve pain in degenerative joint disease in dogs and cats
FR2799638B1 (en) FIXATOR AND VERTEBRAL JOINT
NO995389D0 (en) COX-2 selective carprofen for the treatment of pain and inflammation in dogs
NO20026254D0 (en) Crosslinked hay amylose starch for use in controlled release pharmaceutical formulations and processes for its preparation
AU6278199A (en) Ultrasonic device for providing reversible tissue damage to heart muscle
AU3857900A (en) Computer assisted targeting device for use in orthopaedic surgery
HUP0202319A3 (en) Use of mek inhibitors for the preparation of pharmaceutical compositions treating chronic pain
CY2014020I1 (en) THE USE OF RADIUM-223 TO TARGET CALCIFIED TISSUES FOR PAIN RELIEF AND TREATMENT OF BONE CANCER
FI20021477L (en) Method and system for characterizing and mapping tissue lesions
IS6575A (en) Hydroxyphenyl-piperidin-4-ylidene-methyl-benzamide derivatives to treat pain
IL160928A0 (en) Use of histamine to treat liver disease
AU2003241290A1 (en) Cleaning system for animal litter and bedding
EE200100514A (en) Inhibitors of LFA-1 binding to ICAMs and their use
HUP0202048A3 (en) Use of alpha1betha1 integrin receptor inhibitors and tgf-betha1 inhibitors in the treatment of kidney disease
AU2340397A (en) Use of nicotine to treat liver disease
IL146877A0 (en) System and method for delivering a medical treatment to a treatment site
PL338234A1 (en) Derivatives of aminoethylphenoxyacetic acid as well as drugs capable to relieve pain and to assist in removing urinary calculus in urolithiasis cases
IS6563A (en) Hydroxyphenyl-piperazinyl-methyl-benzamide derivatives to treat pain
IS6574A (en) Quinolinyl-piperidin-4-ylidene-methyl-benzamide derivatives to treat pain
EP1230922A4 (en) AGENTS FOR PROMOTING FATTENING ANIMALS AND METHOD FOR PROMOTING FATTENING
GB2356229B (en) Use of sleeve joints to control moment in pipes
AU6557900A (en) Reduction of malodour in soiled animal litter
IT1285433B1 (en) PLANT FOR THE TRANSFORMATION INTO BALES OF URBAN SOLID WASTE
GB2354500B (en) Apparatus for assisting in the clearing of leaf litter
EP1323734A4 (en) BINDING PROTEIN TO IRAP

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application